Iron is a potential key mediator of glutamate excitotoxicity in spinal cord motor neurons

被引:32
作者
Yu, Jixu [1 ]
Guo, Yansu [1 ,2 ]
Sun, Mengmeng [1 ]
Li, Bin [1 ]
Zhang, Yuesheng [1 ,3 ]
Li, Chunyan [1 ,2 ]
机构
[1] Hebei Med Univ, Hosp 2, Dept Neurol, Shijiazhuang 050000, Hebei, Peoples R China
[2] Inst Cardiocerebrovasc Dis, Shijiazhuang, Hebei, Peoples R China
[3] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA
关键词
Glutamate excitotoxicity; Neuron degeneration; Iron; Oxidative stress; ALZHEIMER-DISEASE; OXIDATIVE STRESS; NEUROTOXICITY; TRANSPORTER; MECHANISMS; EXPRESSION; PROTEIN; CLONING; GENE; RATS;
D O I
10.1016/j.brainres.2008.12.030
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Threohydroxyaspartate (THA)-induced glutamate excitotoxicity in organotypic culture of rat spinal cord is a well-known model of motor neuron degeneration. THA causes accumulation of synaptic glutamate and over stimulation of the postsynaptic receptor by inhibiting glutamate uptake. This model has also been used to identify agents that inhibit glutamate excitotoxicity by increasing the expression of glutamate transporter. We now show that THA also increases iron level in rat spinal cord tissue, with concomitant modulation of key iron transport and storage proteins, including transferrin receptor, divalent metal-ion transporter 1 and ferritin. More significantly, iron chelator deferoxamine (DFO) was able to completely prevent THA-induced motor neuron degeneration. The protective effect of DFO did not involve enhancing glutamate uptake. These data provide new mechanistic insight into THA-induced glutamate excitotoxicity and suggest that blocking THA-induced iron rise alone may be sufficient for prevention of glutamate excitotoxicity. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:102 / 107
页数:6
相关论文
共 26 条
  • [1] GLUTAMATE-INDUCED NEURONAL DEATH - A SUCCESSION OF NECROSIS OR APOPTOSIS DEPENDING ON MITOCHONDRIAL-FUNCTION
    ANKARCRONA, M
    DYPBUKT, JM
    BONFOCO, E
    ZHIVOTOVSKY, B
    ORRENIUS, S
    LIPTON, SA
    NICOTERA, P
    [J]. NEURON, 1995, 15 (04) : 961 - 973
  • [2] New perspectives on iron: An introduction
    Boldt, DH
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1999, 318 (04) : 207 - 212
  • [3] AMPA exposures induce mitochondrial Ca2+ overload and ROS generation in spinal motor neurons in vitro
    Carriedo, SG
    Sensi, SL
    Yin, HZ
    Weiss, JH
    [J]. JOURNAL OF NEUROSCIENCE, 2000, 20 (01) : 240 - 250
  • [4] Carriedo SG, 1998, J NEUROSCI, V18, P7727
  • [5] Casadesus G, 2004, J ALZHEIMERS DIS, V6, P165
  • [6] Iron: The redox-active center of oxidative stress in Alzheimer disease
    Castellani, Rudy J.
    Moreira, Paula I.
    Liu, Gang
    Dobson, Jon
    Perry, George
    Smith, Mark A.
    Zhu, Xiongwei
    [J]. NEUROCHEMICAL RESEARCH, 2007, 32 (10) : 1640 - 1645
  • [7] GLUTAMATE NEUROTOXICITY AND DISEASES OF THE NERVOUS-SYSTEM
    CHOI, DW
    [J]. NEURON, 1988, 1 (08) : 623 - 634
  • [8] Superoxide dismutase 1 modulates expression of transferrin receptor
    Danzeisen, R
    Achsel, T
    Bederke, U
    Cozzolino, M
    Crosio, C
    Ferri, A
    Frenzel, M
    Gralla, EB
    Huber, L
    Ludolph, A
    Nencini, M
    Rotilio, G
    Valentine, JS
    Carrì, MT
    [J]. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY, 2006, 11 (04): : 489 - 498
  • [9] ALTERED BRAIN METABOLISM OF IRON AS A CAUSE OF NEURODEGENERATIVE DISEASES
    GERLACH, M
    BENSHACHAR, D
    RIEDERER, P
    YOUDIM, MBH
    [J]. JOURNAL OF NEUROCHEMISTRY, 1994, 63 (03) : 793 - 807
  • [10] FLUOROMETRIC DETERMINATION OF ASPARTATE GLUTAMATE AND GAMMA-AMINOBUTYRATE IN NERVE TISSUE USING ENZYMIC METHODS
    GRAHAM, LT
    APRISON, MH
    [J]. ANALYTICAL BIOCHEMISTRY, 1966, 15 (03) : 487 - &